CXCR4 and age-related macular degeneration: Although SDF1α/CXCR4 axis is upregulation in hypoxia induction after anti-angiogenesis therapy, AMD-NPs combined with conventional sorafenib therapy or VEGF siRNA inhibition of CXCR4 can prevent the infiltration of TAMs [30].